Braidwell’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
TCM
FLAM
BBA
5VM
VPC
BG
Braidwell's TECX Position: Q2 2026 in Review
Braidwell reduced its Tectonic Therapeutic (TECX) stake by 30% in Q2 2026, selling an estimated $7.35M and leaving 596,900 shares worth $20.5M. The position accounts for 0.76% of the portfolio, ranked #53.
Braidwell first reported a position in TECX in Q3 2025 and has held it in 4 quarters since. The position peaked at $26.2M in Q1 2026. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.
- Braidwell held 596,900 shares of Tectonic Therapeutic worth $20.5M as of Q2 2026.
- Braidwell sold 250,251 Tectonic Therapeutic shares in Q2 2026, an estimated $7.35M.
- Tectonic Therapeutic made up 0.76% of Braidwell's portfolio in Q2 2026, its #53 holding.
- Braidwell first reported a position in Tectonic Therapeutic in Q3 2025 and has held it in 4 quarters since.
- Braidwell's Tectonic Therapeutic position peaked at $26.2M in Q1 2026.
- 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.
Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.